EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of a simple method for testing aztreonam and ceftazidime-avibactam synergy in New Delhi metallo-beta-lactamase producing Enterobacterales

Salman Khan, Arghya Das iD, Deepali Vashisth iD, Anwita Mishra iD, Ashima Jain Vidyarthi, Raghav Gupta iD, Nazneen Nahar Begam iD, Babita Kataria iD, Sushma Bhatnagar

PLOS ONE · 17.05.2024 · 19 (5) · e0303753

DOI: 10.1371/journal.pone.0303753 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 17.05.2024. Verfasst von Salman Khan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, National Cancer Institute, All India Institute of Medical Sciences (Jhajjar-campus), New Delhi, India. Hauptthemen laut MEDLINE: Ceftazidime, Aztreonam, Azabicyclo Compounds, Drug Combinations. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NDM-producing carbapenem-resistant bacterial infections became a challenge for clinicians. Combination therapy of aztreonam and ceftazidime-avibactam is a prudent choice for these infections. However, there is still no recommendation of a practically feasible method for testing aztreonam and ceftazidime-avibactam synergy. We proposed a simple method for testing aztreonam and ceftazidime-avibactam synergy and compared it with reference broth micro-dilution and other methods. Carbapenem-resistant Enterobacterales clinical isolates were screened for the presence of the NDM gene by the Carba R test. NDM harbouring isolates were tested for aztreonam and ceftazidime-avibactam synergy by broth microdilution (reference method), E strip-disc diffusion, double disc diffusion, and disc replacement methods. In the newly proposed method, the MHA medium was supplemented with ceftazidime-avibactam (corresponding to an aztreonam concentration of 4μg/ml). The MHA medium was then inoculated with the standard inoculum (0.5 McFarland) of the test organism. An AZT disc (30 μg) was placed on the supplemented MHA medium, and the medium was incubated overnight at 37°C. Aztreonam zone diameter on the supplemented MHA medium (in the presence of ceftazidime-avibactam) was compared with that from a standard disc diffusion plate (without ceftazidime-avibactam), performed in parallel. Interpretation of synergy was based on the restoration of aztreonam zone diameter (in the presence of ceftazidime-avibactam) crossing the CLSI susceptibility breakpoint, i.e., ≥ 21 mm. Of 37 carbapenem-resistant NDM-producing isolates, 35 (94.6%) were resistant to aztreonam and tested synergy positive by the proposed method. Its sensitivity and specificity were 97.14% and 100%, respectively. Cohen’s kappa value showed substantial agreement of the reference method with the proposed method (κ = 0.78) but no other methods. The proposed method is simple, easily interpretable, and showed excellent sensitivity, specificity, and agreement with the reference method. Therefore, the new method is feasible and reliable for testing aztreonam synergy with avibactam in NDM-producing Enterobacterales.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeftazidimeAztreonamAzabicyclo CompoundsDrug Combinationsbeta-LactamasesMicrobial Sensitivity TestsAnti-Bacterial AgentsEnterobacteriaceaeHumansDrug SynergismEnterobacteriaceae Infections

Substanzen

CeftazidimeAztreonamAzabicyclo CompoundsDrug Combinationsbeta-LactamasesAnti-Bacterial Agentsavibactam, ceftazidime drug combinationbeta-lactamase NDM-1

Autor:innen und Institutionen

  • Department of Microbiology, National Cancer Institute, All India Institute of Medical Sciences (Jhajjar-campus), New Delhi, India.
  • Department of Microbiology, All India Institute of Medical Sciences, Madurai, India.
  • Department of Microbiology, Vallabhbhai Patel Chest Institute, New Delhi, India.
  • Department of Microbiology, Mahamana Pandit Madan Mohan Malviya Cancer Centre and Homi Bhabha Cancer Hospital, Varanasi, Uttar Pradesh, India.
  • Department of Oncoanesthesia and Palliative Medicine, National Cancer Institute, All India Institute of Medical Sciences (Jhajjar-Campus), New Delhi, India.
  • Department of Infectious Diseases, Institute of Post-Graduate Medical Education and Research, Kolkata, India.

ORCID-Profile: Arghya Das, Deepali Vashisth, Anwita Mishra, Raghav Gupta, Nazneen Nahar Begam, Babita Kataria

Zitieren

APA

Khan, S., Das, A., Vashisth, D., Mishra, A., Vidyarthi, A. J., Gupta, R., Begam, N. N., Kataria, B., & Bhatnagar, S. (2024). Evaluation of a simple method for testing aztreonam and ceftazidime-avibactam synergy in New Delhi metallo-beta-lactamase producing Enterobacterales. PLOS ONE, 19(5), e0303753. https://doi.org/10.1371/journal.pone.0303753

Vancouver

Khan S, Das A, Vashisth D, Mishra A, Vidyarthi AJ, Gupta R, et al. Evaluation of a simple method for testing aztreonam and ceftazidime-avibactam synergy in New Delhi metallo-beta-lactamase producing Enterobacterales. PLOS ONE. 2024;19(5):e0303753. doi:10.1371/journal.pone.0303753

BibTeX
@article{Khan2024,
  author = {Khan, Salman and Das, Arghya and Vashisth, Deepali and Mishra, Anwita and Vidyarthi, Ashima Jain and Gupta, Raghav and Begam, Nazneen Nahar and Kataria, Babita and Bhatnagar, Sushma},
  title = {Evaluation of a simple method for testing aztreonam and ceftazidime-avibactam synergy in New Delhi metallo-beta-lactamase producing Enterobacterales},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {5},
  pages = {e0303753},
  doi = {10.1371/journal.pone.0303753}
}
Kostenlos starten →